Gastroparesis risk factors: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Gastroparesis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==Overview== ==Risk Fa...") |
No edit summary |
||
| (9 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gastroparesis}} | {{Gastroparesis}} | ||
{{CMG}}{{AE}}{{MSI}} | |||
==Overview== | ==Overview== | ||
Common [[risk factors]] associated with gastroparesis includal [[viral infection]], [[cholecystectomy]], [[diabetes]], [[gastrectomy]], [[collagen vascular diseases]], [[Neurological disease|neurological diseases]], use of medication that inhibits certain nerve signals ([[anticholinergic]] medication). | |||
==Risk Factors== | ==Risk Factors== | ||
Risk factors for gastroparesis include: | Risk factors for gastroparesis include:<ref name="pmid26406565">{{cite journal |vauthors=Tack J, Carbone F, Rotondo A |title=Gastroparesis |journal=Curr. Opin. Gastroenterol. |volume=31 |issue=6 |pages=499–505 |year=2015 |pmid=26406565 |doi=10.1097/MOG.0000000000000220 |url=}}</ref><ref name="pmid23147521">{{cite journal |vauthors=Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L |title=Clinical guideline: management of gastroparesis |journal=Am. J. Gastroenterol. |volume=108 |issue=1 |pages=18–37; quiz 38 |year=2013 |pmid=23147521 |pmc=3722580 |doi=10.1038/ajg.2012.373 |url=}}</ref><ref name="pmid25874755">{{cite journal |vauthors=Stein B, Everhart KK, Lacy BE |title=Gastroparesis: A Review of Current Diagnosis and Treatment Options |journal=J. Clin. Gastroenterol. |volume=49 |issue=7 |pages=550–8 |year=2015 |pmid=25874755 |doi=10.1097/MCG.0000000000000320 |url=}}</ref> | ||
* [[Viral infection]] | |||
* [[Cholecystectomy]] | |||
* [[Diabetes]] | * [[Diabetes]] | ||
* [[Gastrectomy]] | * [[Gastrectomy]] | ||
* [[ | * [[Collagen vascular diseases]] | ||
* [[Neurological disease|Neurological diseases]] | |||
* Use of medication that inhibits certain nerve signals ([[anticholinergic]] medication) | * Use of medication that inhibits certain nerve signals ([[anticholinergic]] medication) | ||
| Line 17: | Line 20: | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Gastroenterology]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 17:09, 8 February 2018
|
Gastroparesis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gastroparesis risk factors On the Web |
|
American Roentgen Ray Society Images of Gastroparesis risk factors |
|
Risk calculators and risk factors for Gastroparesis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]
Overview
Common risk factors associated with gastroparesis includal viral infection, cholecystectomy, diabetes, gastrectomy, collagen vascular diseases, neurological diseases, use of medication that inhibits certain nerve signals (anticholinergic medication).
Risk Factors
Risk factors for gastroparesis include:[1][2][3]
- Viral infection
- Cholecystectomy
- Diabetes
- Gastrectomy
- Collagen vascular diseases
- Neurological diseases
- Use of medication that inhibits certain nerve signals (anticholinergic medication)
References
- ↑ Tack J, Carbone F, Rotondo A (2015). "Gastroparesis". Curr. Opin. Gastroenterol. 31 (6): 499–505. doi:10.1097/MOG.0000000000000220. PMID 26406565.
- ↑ Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L (2013). "Clinical guideline: management of gastroparesis". Am. J. Gastroenterol. 108 (1): 18–37, quiz 38. doi:10.1038/ajg.2012.373. PMC 3722580. PMID 23147521.
- ↑ Stein B, Everhart KK, Lacy BE (2015). "Gastroparesis: A Review of Current Diagnosis and Treatment Options". J. Clin. Gastroenterol. 49 (7): 550–8. doi:10.1097/MCG.0000000000000320. PMID 25874755.